{"cord_uid": "0pmo3opx", "sourcedb": "PMC", "sourceid": "PMC5431086", "divid": "5", "text": "cytotoxins to cancer cells 14 . One of these agents , a cyclic version of the NGR peptide complexed to the human tumor necrosis factor alpha , is currently undergoing Phase III clinical trials in mesothelioma 15 .", "project": "cdlai_CORD-19", "denotations": [{"id": 1, "span": {"begin": 78, "end": 82}, "obj": "ne"}]}